Artículo
Outbreak of Klebsiella pneumoniae ST11 Resistant to Ceftazidime-Avibactam Producing KPC-31 and the Novel Variant KPC-115 during COVID-19 Pandemic in Argentina
Nicola, Federico; Cejas, Daniela
; Gonzalez Espinosa, Francisco Eduardo
; Relloso, Silvia; Herrera, Fabián; Bonvehí, Pablo; Smayevsky, Jorgelina; Figueroa Espinosa, Roque Arnulfo
; Gutkind, Gabriel Osvaldo
; Radice, Marcela Alejandra
Fecha de publicación:
11/2022
Editorial:
American Society for Microbiology
Revista:
Microbiology Spectrum
ISSN:
2165-0497
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
We describe an outbreak of Klebsiella pneumoniae sequence type 11 (ST11) producing KPC variants resistant to ceftazidime-avibactam. Six patients hospitalized in the intensive care unit (mostly due to critical COVID pneumonia) presented infection or colonization by this bacterium. They had several comorbidities and required mechanical ventilation, central venous catheters, and urinary catheters. All 6 patients had a history of fecal colonization with KPC-producing Enterobacterales (KPC-E). Three of them had previous episodes of infection with ceftazidime-avibactam-susceptible KPC-producing K. pneumoniae, which were treated with ceftazidime-avibactam. Several phenotypic methods failed to detect carbapenemase production in these 6 ceftazidime-avibactam-resistant isolates, and they showed in vitro susceptibility to imipenem and meropenem. All of them rendered positive results for blaKPC by PCR, and amplicon sequencing identified blaKPC-31 variant in 5 isolates and a novel variant, named blaKPC-115, in the other. Moreover, matrix-assisted laser desorption ionization–time of flight mass spectrometry was able to detect KPC in all isolates. Ceftazidime-avibactam-resistant isolates, as well as those recovered from previous infection episodes (KPC-3-producing K. pneumoniae, ceftazidime-avibactam susceptible), displayed a unique pulse type and belonged to ST11. Based on whole-genome sequencing results of selected isolates, less than 7 single-nucleotide polymorphisms were identified among them, which was indicative of the presence of a unique clone. Both in vivo selection and horizontal transmission seemed to have occurred in our hospital. Detection of these strains is challenging for the laboratory. History of previous KPC-E infections or colonization and systematic testing for resistance to ceftazidime-avibactam might help raise awareness of this possibility.
Palabras clave:
CEFTAZIDIME/AVIBACTAM
,
KPC MUTANTS
,
KPC-31
,
KPC-115
,
COVID-19
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(OCA HOUSSAY)
Articulos de OFICINA DE COORDINACION ADMINISTRATIVA HOUSSAY
Articulos de OFICINA DE COORDINACION ADMINISTRATIVA HOUSSAY
Citación
Nicola, Federico; Cejas, Daniela; Gonzalez Espinosa, Francisco Eduardo; Relloso, Silvia; Herrera, Fabián; et al.; Outbreak of Klebsiella pneumoniae ST11 Resistant to Ceftazidime-Avibactam Producing KPC-31 and the Novel Variant KPC-115 during COVID-19 Pandemic in Argentina; American Society for Microbiology; Microbiology Spectrum; 10; 6; 11-2022; 1-7
Compartir
Altmétricas